Balanced news tone
News Sentiment
SENORES sentiment intelligence
SENORES PHARMACEUTICALS L news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
19 relevant articles
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+1.9% over one week, +18.4% over four weeks, trend active, and materially above fair value.
SENORES PHARMACEUTICALS LTD. Share Price Today Up 6%
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
80/100 classification
One-week reaction
1.9%
Price digesting
Trend fit
Trend active
18.4% over four weeks
Fair value
82.9%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
5
Neutral
14
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Equitymaster
Direct company coverage
SENORES PHARMACEUTICALS LTD. Share Price Today Up 6%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 09:40
- Source
- Equitymaster
scanx.trade
Direct company coverage
Senores Pharmaceuticals to hold investor conference on June 12
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Senores Pharmaceuticals' (NSE:SENORES) Solid Profits Have Weak Fundamentals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- simplywall.st
scanx.trade
Direct company coverage
Senores Pharma to hold investor meet on May 28
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Senores FY26 PAT Surges 108%; Targets 30-40% Revenue Growth
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 19 May 2026 07:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Should You Be Adding Senores Pharmaceuticals (NSE:SENORES) To Your Watchlist Today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- simplywall.st
CNBC TV18
Direct company coverage
Senores Pharma Q4 Results: Stock drops 5% on sequential earnings weakness
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- CNBC TV18
scanx.trade
Direct company coverage
Senores Pharmaceuticals Schedules Board Meeting on May 14, 2026 to Approve FY26 Audited Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- scanx.trade
Business Standard
Direct company coverage
Stocks to buy: Apollo Hospitals, Senores Pharma among analyst's top picks
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- Business Standard
Upstox
Direct company coverage
SENORES PHARMACEUTICALS L Share Price Today - Live SENORES Stock Price for NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 11:37
- Source
- Upstox
scanx.trade
Direct company coverage
Senores Pharmaceuticals Forms Strategic US Joint Venture for Federal Contracts
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Senores Pharmaceuticals Files SAST Disclosure for ₹95.00 Crore Warrant Allotment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Apr 2026 07:00
- Source
- scanx.trade
Business Standard
Direct company coverage
Sundaram Finance, Senores trading near breakout points; check strategy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Feb 2026 08:00
- Source
- Business Standard
simplywall.st
Direct company coverage
Senores Pharmaceuticals Limited (NSE:SENORES) Released Earnings Last Week And Analysts Lifted Their Price Target To ₹1,081
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 23 Jan 2026 08:00
- Source
- simplywall.st
Moneycontrol.com
Direct company coverage
Buy Senores Pharma; target of Rs 1045: Choice Institutional Equities
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 21 Jan 2026 08:00
- Source
- Moneycontrol.com
scanx.trade
Direct company coverage
Senores Pharmaceuticals Reports 86% Jump in Q3 Consolidated Net Profit to ₹317 Million
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 20 Jan 2026 08:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Senores Pharmaceuticals Board Approves ₹950 Crore Convertible Warrant Issue to Promoters
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jan 2026 08:00
- Source
- scanx.trade
HDFC Sky
Direct company coverage
Senores Pharma Shares price Rise 5% After Q2FY26 Profit Jump
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 06 Nov 2025 08:00
- Source
- HDFC Sky
TradingView
Direct company coverage
SENORES Forecast — Price Target — Prediction for 2027
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 28 Oct 2025 13:36
- Source
- TradingView